QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Aley, K. O. Articles by Levine, J. D. Search for Related Content PubMed PubMed Citation Articles by Aley, K. O. Articles by Levine, J. D.

 Previous Article  |  Next Article 

Volume 17, Number 20, Issue of October 15, 1997 pp. 8018-8023
Copyright ©1997 Society for Neuroscience

Different Mechanisms Mediate Development and Expression of Tolerance and Dependence for Peripheral µ-Opioid Antinociception in Rat

Received June 6, 1997; revised August 1, 1997; accepted August 1, 1997.

Kochuvelikakam O. Aley and Jon D. Levine

Department of Anatomy, Medicine, and Oral Surgery and Division of Neuroscience, University of California, San Francisco, California 94143

The µ-opioid [D-Ala²,N-Me-Phe⁴,Gly-ol⁵]-enkephalin (DAMGO) exerts a peripheral antinociceptive effect against prostaglandin E₂ (PGE₂)-induced mechanical hyperalgesia in the hindpaw of the rat. Tolerance and dependence develop to this effect. We have shown previously that tolerance and dependence can be dissociated and are mediated by different second messenger systems. In the present study, we evaluated whether the same or different second messenger systems mediate the development of this peripheral opioid tolerance or dependence compared with the expression of the loss of antinociceptive effect or rebound opioid antagonist hyperalgesia (i.e., expression of tolerance and dependence). DAMGO-induced tolerance was prevented by pretreatment with the nitric oxide synthase inhibitor N^G-methyl-L-arginine (NMLA) but not by the protein kinase C (PKC) inhibitor chelerythrine, the adenylyl cyclase inhibitor 2,5-dideoxyadenosine (ddA), or the calcium chelators 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-octyl ester (TMB-8) and 2-[(2-bis-[carboxymethyl]amino-5-methylphenoxy)-methyl]-6-methoxy-8-bis[carboxymethyl]aminoquinoline (Quin-2). Once established, however, expression of DAMGO tolerance was acutely reversed by TMB-8 or Quin-2 but not by chelerythrine or NMLA. In contrast, naloxone-precipitated hyperalgesia in DAMGO-tolerant paws, a measure of dependence, was blocked by pretreatment with chelerythrine but not by NMLA, ddA, TMB-8, or Quin-2. Naloxone-precipitated hyperalgesia in DAMGO-tolerant paws was acutely reversed by chelerythrine, ddA, TMB-8, or Quin-2 but not by NMLA. Taken together, these results provide the first evidence that different mechanisms mediate the development and expression of both tolerance and dependence to the peripheral antinociceptive effect of DAMGO. However, although the development of tolerance and dependence are entirely separable, the expression of tolerance and dependence shares common calcium-dependent mechanisms.

Key words: protein kinase A; protein kinase C; nitric oxide; adenylyl cyclase; calcium; opioids; nociception; prostaglandin E₂

This article has been cited by other articles:

				D. J. Daniels, N. R. Lenard, C. L. Etienne, P.-Y. Law, S. C. Roerig, and P. S. Portoghese Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series PNAS, December 27, 2005; 102(52): 19208 - 19213. [Abstract] [Full Text] [PDF]

				G. Lim, S. Wang, Q. Zeng, B. Sung, L. Yang, and J. Mao Expression of Spinal NMDA Receptor and PKC{gamma} after Chronic Morphine Is Regulated by Spinal Glucocorticoid Receptor J. Neurosci., November 30, 2005; 25(48): 11145 - 11154. [Abstract] [Full Text] [PDF]

				A. Tasatargil and G. Sadan Reduction in [D-Ala2, NMePhe4, Gly-ol5]Enkephalin-Induced Peripheral Antinociception in Diabetic Rats: The Role of the L-Arginine/Nitric Oxide/Cyclic Guanosine Monophosphate Pathway Anesth. Analg., January 1, 2004; 98(1): 185 - 192. [Abstract] [Full Text] [PDF]

				J. F. Nitsche, A. G. P. Schuller, M. A. King, M. Zengh, G. W. Pasternak, and J. E. Pintar Genetic Dissociation of Opiate Tolerance and Physical Dependence in delta -Opioid Receptor-1 and Preproenkephalin Knock-Out Mice J. Neurosci., December 15, 2002; 22(24): 10906 - 10913. [Abstract] [Full Text] [PDF]

				K. O. Aley and J. D. Levine Role of Protein Kinase A in the Maintenance of Inflammatory Pain J. Neurosci., March 15, 1999; 19(6): 2181 - 2186. [Abstract] [Full Text] [PDF]

				S. G. Khasar, G. McCarter, and J. D. Levine Epinephrine Produces a beta -Adrenergic Receptor-Mediated Mechanical Hyperalgesia and In Vitro Sensitization of Rat Nociceptors J Neurophysiol, March 1, 1999; 81(3): 1104 - 1112. [Abstract] [Full Text] [PDF]

				K. O. Aley, G. McCarter, and J. D. Levine Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat J. Neurosci., September 1, 1998; 18(17): 7008 - 7014. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help